Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin in Prevention and Treatment of COVID-19
TCTR20210929002Phase 3Recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ivermectin in coronavirus disease 2019 (COVID-19), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Aug 2021; status: recruiting.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20210929002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210929002.